Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
| Status: | Available |
|---|---|
| Conditions: | Infectious Disease, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery, Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Contact: | Jane E Koehler, MA, MD |
| Email: | jkoehler@medicine.ucsf.edu |
| Phone: | 415-476-3536 |
Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be
treated with sodium stibogluconate (Pentostam).
treated with sodium stibogluconate (Pentostam).
Inclusion Criteria:
- Biopsy proven new world cutaneous or mucocutaneous leishmania
Exclusion Criteria:
- Prolonged QT
- Liver disease
- Pancreatitis
We found this trial at
1
site
Click here to add this to my saved trials
